close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Corp. Common Shares

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Wait for Zomedica to Give Up More of its Meme Stock Gains ↗
It's not there yet, but if ZOM stock pulls back another 50% or so, the risk/return proposition will be more in your favor. 
Via InvestorPlace
News headline image
Zomedica Stock Still Has a Rocky Few Months Left Ahead of It ↗
ZOM stock is rife with massive potential. But it's the same potential that has gone unfulfilled for the past few months. 
Via InvestorPlace
News headline image
A Little Patience Could Go a Long Way For ZOM Stock ↗
Now that Truforma is in the market, it’s time for investors to see revenue growth 
Via InvestorPlace
News headline image
2 Risky Meme Stocks You Don't Want to Hold With 'Diamond Hands' ↗
Some stocks you can buy and forget. With Zomedica and ContextLogic, you'll want to keep a much closer eye on matters. 
Via The Motley Fool
News headline image
Wait for the Reddit Set to Sell Before Buying Bionano Stock ↗
Genomics play BNGO stock may pay off down the road, but wait for a meme stock investor exodus before making it a buy 
Via InvestorPlace
News headline image
Zomedica Is Way Undervalued Here as Its Gear Is Catching On ↗
InvestorPlace’s Mark Hake estimates Zomedica is worth between $1.11 and $1.61 a share. That makes ZOM stock a buy. Here’s why I agree. 
Via InvestorPlace
News headline image
Radio Silence May Indicate a Problem for Zomedica Stock ↗
Zomedica is due to report results for the current quarter on Aug. 11. Until then, investors have nothing with which to weigh ZOM stock. 
Via InvestorPlace
News headline image
Zomedica Stock Has More Headwinds Than the Rest of the Pet Industry ↗
Drilling into pet industry details reveals a key risk factor that some ZOM stock believers may be ignoring. 
Via InvestorPlace
News headline image
Risk-Reward Ratio of Zomedica Stock Looks Unfavorable ↗
Zomedica may be facing tough competition, and there are indications that Truforma is not popular so far. ZOM stock looks very risky. 
Via InvestorPlace
News headline image
Zomedica Pharmaceuticals Has to Prove Itself to Long-Term Investors ↗
The hype surrounding ZOM stock has worn off, and it's now time for the company to prove its value through its sales numbers. 
Via InvestorPlace
News headline image
Zomedica Is Good Value and May Be Worth $1.36 — Or More ↗
Zomedica is good value and is on the acquisition warpath. ZOM stock is worth $1.36 on average, providing an average 20% ROI over 2 years. 
Via InvestorPlace
News headline image
Zomedica Is Surprisingly Cheap Even as Commercialization Commences ↗
ZOM stock has spiked sharply this year, but a recent price pullback could signal an ideal entry point for pet care market investors. 
Via InvestorPlace
News headline image
Better Robinhood Penny Stock: Sundial Growers vs. Zomedica ↗
Both have been huge winners in recent months. 
Via The Motley Fool
News headline image
Zomedica’s Risks Are Too Big to Ignore ↗
You may like ZOM stock as a pet lover, but not for its fundamentals, nor its valuation until it starts having credible financial results. 
Via InvestorPlace
News headline image
Zomedica’s High Share Count Creates Challenges for ZOM Stock ↗
Zomedica has promising growth potential, but its high share count makes ZOM stock a risky investment. Here's what investors should know. 
Via InvestorPlace
Topics Bonds
News headline image
Zomedica Stock Will Be Worth The Risk After Another Drop ↗
Another pullback in ZOM stock will put this long-term speculative play's odds in your favor if its Truforma product catches on. 
Via InvestorPlace
News headline image
Right-Priced Zomedica Could Be an Investor’s Best Friend ↗
The skeptics might misinterpret the company's first-quarter revenue data, but a deeper dive should uncover reasons to hold on to ZOM stock. 
Via InvestorPlace
Social Distancing Creates Pet-Buying Boom that Sends the Industry to New Heights
Via FinancialNewsMedia
News headline image
Bets on Zomedica’s In-Office Vet Test Could Payoff or Bust by Year-End ↗
ZOM stock is pure speculation as pet owners are spending more on keeping their dogs and cats alive. 
Via InvestorPlace
News headline image
Is Zomedica Making a Change For the Better? ↗
Wait for evidence of success before making a speculative bet on ZOM stock 
Via InvestorPlace
News headline image
Zomedica Stock Can Return to a Dollar If It Focuses on Just One Thing ↗
Zomedica is testing its support levels at current prices. What does the maker of diagnostic equipment need to do to get ZOM stock back to $1? 
Via InvestorPlace
News headline image
Zomedica Stock Is At Serious Risk Unless Bulls Commit ↗
ZOM stock makes for a better trading vehicle than an investment in spite of their noble effort to heal. It needs to hold recent lows or else. 
Via InvestorPlace
News headline image
Could Zomedica Be a Millionaire-Maker Stock? ↗
Or will speculation lead to major disappointment? 
Via The Motley Fool
News headline image
Why Zomedica Stock Popped Today ↗
A new executive will oversee the company's growth initiatives. 
Via The Motley Fool
News headline image
Zomedica Stock Will Burn You as High-Growth Stocks Start to Flag ↗
The bull market has certainly made new investors look like geniuses, as usual. But now is the true test and ZOM stock isn't likely to pass. 
Via InvestorPlace
News headline image
Zomedica Stock Is Clearly Going to Keep Moving in the Wrong Direction ↗
Zom stock is sliding downward due to its precarious financial situation. With no sales, it's best for investors to steer clear. 
Via InvestorPlace
News headline image
Zomedica Is Now a Low-Probability Gamble ↗
ZOM stock attracts plenty of attention for its underlying pet care business and its wild potential but this game may be over. 
Via InvestorPlace
News headline image
Zomedica Stock Is Another Hyped-Up Reddit Play That Can’t Escape Reality ↗
Zomedica has potential in a niche business. But the price of ZOM stock does not yet reflect that. This will change as day traders move on. 
Via InvestorPlace
News headline image
Are Penny Stocks A Solution To Inflation? ↗
Inflationary fears are back in the news cycle but is that bad for all stocks? 
Via Talk Markets
News headline image
Why Zomedica Stock Isn’t Worth Buying Right Now ↗
If Truforma truly is a game-changer, there’s hope the company could grab part of a potential $10.5 billion animal diagnostics market. 
Via InvestorPlace
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today